Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders
Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
Aeterna Zentaris and Ceapro Complete Merger Transaction
Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date
Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Aeterna Zentaris Reports First Quarter 2024 Financial Results
Aeterna Zentaris Announces Effective Date of Share Consolidation
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.